News: Portfolio 2009
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director; Announces Positive Top Line Results of its Clinical Study of LT-NS001 vs. naproxen and Achievement of Financing Milestone
(continued)
About Logical Therapeutics, Inc.
Logical Therapeutics, Inc. is a privately held biotechnology company based in Waltham, Massachusetts. Logical Therapeutics is developing drugs to treat a variety of medical conditions that are associated with excessive inflammation, including osteoarthritis and rheumatoid arthritis. For more information on Logical Therapeutics, visit the company's website at www.logicaltherapeutics.com or send an email to info@logicaltherapeutics.com
Jennifer Bannan
Zer0 to 5ive
412-580-3675
jen@0to5.com